Platelet-rich plasma: inconclusive evidence of reproductive outcomes in menopausal women
Authors:
- 22 June 2022
- journal article
- review article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 39 (9) , 1987-1991
Abstract
Purpose The use of platelet-rich plasma is being investigated in reproductive medicine and clinically promoted as a fertility treatment for menopause. We aimed to review the literature on the impact of PRP on fertility in menopause. Methods A literature search was performed using the PubMed and MEDLINE search engines. The search was limited to the English language. Articles studying PRP use in menopause were selected for the purpose of this review. Results Limited case reports and case series studied fertility outcomes of PRP in menopause. Randomized controlled trials are lacking. Furthermore, no studies have been conducted to evaluate the effect of different PRP concentrations, injection techniques, or side effects on reproductive outcomes in menopausal women. Conclusion There is a dearth of data to support the routine implementation of intraovarian PRP injections for fertility restoration in menopausal women. Patients considering such therapy need to be well aware of the lack of adequate data for PRP use in menopause and should be counseled accordingly.Keywords
This publication has 30 references indexed in Scilit:
- Cytokine-release kinetics of platelet-rich plasma according to various activation protocolsBone & Joint Research, 2016
- Use of Platelet‐Rich Plasma in Intra‐Articular Knee Injections for Osteoarthritis: A Systematic ReviewPM&R, 2015
- Ovarian stem cells: From basic to clinical applicationsWorld Journal of Stem Cells, 2015
- Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammationBlood, 2014
- Sports Medicine Applications of Platelet Rich PlasmaCurrent Pharmaceutical Biotechnology, 2012
- Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?Current Pharmaceutical Biotechnology, 2012
- Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age womenNature Medicine, 2012
- Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesisBlood, 2011
- Three-minute critical appraisal of a case series articleIndian Journal of Orthopaedics, 2011
- Ovarian Aging: Mechanisms and Clinical ConsequencesEndocrine Reviews, 2009